킴스온라인

주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기

최근 해외학술대회의 주요 발표내용을 제공합니다.

컨퍼런스 커버리지

International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress

17 July - 21 July, 2021, United States

High-dose abelacimab bests enoxaparin for VTE prevention

2022-01-14

Giving the factor XI inhibitor abelacimab postoperatively was at least similarly effective as, or even superior to, the standard care of enoxaparin in preventing venous thromboembolism (VTE) following total knee arthroplasty, without increasing bleeding risk, according to the ANT-005 TKA trial presented at ISTH 2021.
Post-extraction bleeding in patients on NOACs: Does tranexamic acid help?

2022-01-14

In patients on non-vitamin K oral anticoagulants (NOACs) who have undergone dental extraction, a 10-percent tranexamic-acid (TXA) mouthwash did not reduce the incidence of oral bleeding following extraction. However, TXA use led to a reduction in the number of total and delayed bleeds, as well as bleeding following multiple extractions, findings from the EXTRACT-NOAC trial have shown.
STASEY confirms safety, efficacy of emicizumab for PwHA with FVIII inhibitors

2022-01-14

The STASEY trial, a large, phase IIIb study evaluating a diverse population of persons with haemophilia A (PwHA) with Factor(F)VIII inhibitors, confirms the safety and efficacy profile of the bispecific monoclonal antibody emicizumab that has been demonstrated in the HAVEN trials.

최근 본 콘텐츠

최근 본 콘텐츠가 없습니다

서울특별시 강남구 테헤란로 8길 33 청원빌딩 1층 (주)킴스
개인정보관리책임자 : 소현정 사업자등록번호 : 214-81-75415 통신판매업신고 : 강남-5166호 대표이사 : 마사키 타카하타
고객센터 : 1544-2930 (09:00~18:00, 주말/공휴일 제외) 팩스 : 02-3019-9380 e-mail : webmaster@kims.co.kr

주요메뉴

최근 본 콘텐츠